RE: Mass Antibody Testing10 Sep 2020 11:24
Completion of AbC-19 self-test usability study
Mon, 7th Sep 2020 07:00
RNS Number : 1510Y
Omega Diagnostics Group PLC
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, announces that the self-test usability study for the UK Rapid Test Consortium's ("UK-RTC") COVID-19 lateral flow antibody test (the "AbC-19™ Rapid test") has concluded.
The study was performed by Ulster University using approximately 2,000 volunteers and completed over the weekend. The AbC-19™ Rapid test has already been CE-Marked for professional use.
Omega remains on track to have production capacity in place this month to produce an initial 100,000 AbC-19™ Rapid test per week, scaling up to 200,000 tests per week capacity in October.
Colin King, CEO of Omega, commented: "We're very pleased that the self-test usability study has completed and that we are progressing towards our goal of MHRA approval for self-test home use.
We know what's happening, the media are confused. With the first batch of home test kits from Abingdon already running out, the first 100,000 kits will be announced by Colin any moment now. Holding firmly